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Summary statement 
Gastric pathologies in an ATP4a knockin mouse model of a mutation responsible for 
the development of gastric neuroendocrine tumors in humans are prevented and 
reverted by adding HCl to the drinking water 
 
ABSTRACT 
 
By whole exome sequencing, we recently identified a missense mutation (p.R703C) in 
the human ATP4a gene, which encodes the proton pump responsible for gastric 
acidification. This mutation causes an aggressive familial type I gastric neuroendocrine 
tumor in homozygous individuals. Affected patients showed an early onset of the 
disease, characterized by gastric hypoacidity, hypergastrinemia, iron-deficiency 
anemia, gastric intestinal metaplasia and, in one case, an associated gastric 
adenocarcinoma. Total gastrectomy was performed as the definitive treatment in all 
affected patients. We now describe the generation and characterization of a knockin 
mouse model for the ATP4aR703C mutation to better understand the tumorigenesis 
process. Homozygous mice recapitulated most of the phenotypical alterations that 
were observed in human patients, strongly suggesting that this mutation is the primary 
alteration responsible for disease development. Homozygous mice developed 
premalignant condition with severe hyperplasia, dysplasia and glandular metaplasia in 
the stomach. Interestingly, gastric acidification in homozygous mice, induced by 
treatment with 3% HCl acid in the drinking water, prevented (if treated from birth) or 
partially reverted (if treated during adulthood) the development of glandular metaplasia 
and dysplasia in the stomach and partially restored the abnormal biochemical 
parameters. We therefore suggest that, in this model, achlorhydria contributes to 
tumorigenesis to a greater extent than hypergastrinemia. Furthermore, our mouse 
model represents a unique and novel tool for studying the pathologies associated with 
disturbances in gastric acid secretion. 
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INTRODUCTION 
 
Type I gastric neuroendocrine tumors (gNETs; also known as gastric 
carcinoids) are multifocal cellular lesions, usually benign in behavior and associated 
with hypochlorhydria and hypergastrinemia (Zhang et al., 2011; Vannella et al., 2012). 
In normal physiological conditions, gastrin is secreted by the G cells located in the 
antrum of the stomach (pyloric glands), and stimulates acid secretion by the gastric 
oxyntic glands, which are located in the corpus region of the stomach. These glands 
are mainly composed of chief (or zymogenic) cells, enterochromaffin-like cells (ECL-
cells) and parietal cells (PCs). Gastric acid secretion is achieved through proton 
pumps (encoded by the ATP4a gene) located in PCs. Gastric acid is also needed for 
the conversion of pepsinogen to pepsin (activated form), and facilitates iron absorption 
in the duodenum (Schubert, 2015). In addition, PCs in humans produce intrinsic factor 
(IF), which is necessary for the absorption of vitamin B12.  
Chronic hypergastrinemia associated with chronic atrophic gastritis, either of 
autoimmune origin or due to Helicobacter pylori infection, results in ECL-cell 
hyperplasia, which is a precursor of gastric NET development in some patients. 
Sporadic type I gastric NETs are associated with progressive destruction of PCs and 
therefore with gastric hypoacidity and megaloblastic anemia due to vitamin B12 
malabsorption. 
The management of type I gastric NETs is still open to debate due to their 
usually relative benign clinical course (Gladdy et al., 2009). Endoscopic mucosal 
resection is often performed (Uygun et al., 2014), however, the recurrence rate is high 
(up to 68%) (Merola et al., 2012). Surgical approaches such as antrectomy to remove 
the source of hypergastrinemia are required for larger polyps or for aggressive forms 
of the tumors showing mucosal invasion (Nikou and Angelopoulos, 2012). 
Gastrin/CCK-2 receptor antagonist drugs such as netazepide (Fossmark et 
al., 2012; Moore et al., 2013) or antibodies against progastrin-releasing peptides have 
also been shown to inhibit ECL-cell hyperplasia. Somatostatin analogs, which inhibit 
gastrin production, have also been proposed as treatment, in view of their 
antisecretory, antiproliferative and antiangiogenic effects (Culler et al., 2011). However, 
these drugs require long-term treatment and are also very expensive (Massironi et al., 
2015). 
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By whole exome sequencing (WES), we recently found a missense mutation 
in the ATP4a gene (p.R703C), which encodes the proton pump in PCs. This mutation 
was responsible for the development of an aggressive form of type I gastric NET in 
homozygous individuals within a consanguineous family (Calvete et al., 2015). This 
atypical gastric NET had a very poor prognosis. The five affected members required 
total gastrectomy, had nodal infiltration and one individual also developed gastric 
adenocarcinoma. The disease was also associated with an earlier age of onset 
(relative to other types of gNETs) and with iron-deficiency anemia rather than 
megaloblastic anemia. Different to the classic type I gastric NETs, PCs were still 
observed in the non-tumor gastric corpus mucosa and IF was produced normally. 
However, these patients did not produce gastric acid normally and this resulted in 
hypergastrinemia. The clinical features of these patients have been described in detail 
in Calvete et al., 2015. The only treatment currently available for these aggressive 
gastric NETs involves total gastrectomy. We have now generated a knockin mouse 
model carrying the equivalent mutation to the one found in these patients in order to 
investigate its causal effects upon the development of the disease and for testing 
potential alternative therapeutic strategies. 
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RESULTS 
 
Phenotype of the ATP4a p.R702C knockin mice 
 
The recessive mutation found in the ATP4a gene (p.R703C) responsible for 
atypical type I familial gastric NETs (Calvete et al., 2015) corresponds to the p.R702C 
mutation in mice. We converted the wild type (WT) CGA (Arg) codon to TGC (Cys) to 
generate the mutated Atp4a knockin (KI) allele (Fig. S1) by homologous recombination 
in embryonic stem (ES) cells (see Materials and Methods). Homozygous animals for 
the knockin allele (KI/KI) did not show obvious developmental defects and were fertile. 
They also had normal behavior, weight and feeding habits.  
For most assays, three mice of each gender were tested at each selected time 
point. Unless otherwise indicated, data from males and females were analyzed 
together to improve statistical power (n=6). The phenotype was already evident at 80 
days of life and did not significantly change over time. We consider the last measured 
timepoint (>350 days) as being the most representative of the pathology development 
(Table 1). 
Homozygous (KI/KI) mice for the Atp4a p.R702C mutation showed a 
pronounced overall thickness and weight of their stomachs (Fig. 1A). Only a slight 
increase in antrum thickness was observed in the KI/KI mice, however, the corpus 
thickness were severely increased (p<0.001) compared to WT mice (Fig. 1B and C).  
No significant differences were observed between WT and heterozygous (KI/+) 
stomachs. In addition, no differences were found in the non-glandular regions of the 
stomach (close to the pylorus and duodenum) among the three genotypes (Table 1).  
When both weight and size of the stomachs were normalized to the total weight 
of the animals (values called mass and size index, respectively), mass index was 
significantly increased (p<0.012) in KI/KI compared to WT mice (Fig. 1D). However, no 
differences were observed in size index (Fig. 1E) suggesting that there is a thickening 
of the stomach wall towards the lumen without altering the total volume of the organ.  
 
Histopathology of the gastric wall in homozygous mutant mice 
The gastric wall hyperplasia observed in KI/KI mice was evaluated by 
hematoxylin and eosin (H&E) staining. In WT stomachs, PCs stained eosinophilic with 
H&E and were found in the neck region of the oxyntic glands (Fig. 2A). Chief 
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(zymogenic) cells stained basophilic with H&E and were located at the gland base (Fig. 
2A). 
In contrast, the KI/KI stomachs showed glandular disorganization and the 
integrity and architecture of the oxyntic glands were compromised. A higher cellularity, 
loss of nuclear polarity, increased number of inflammatory cells, swollen cytoplasms 
and loss of normal gland morphology were observed in the gastric corpus of KI/KI 
mice. Basophilic staining with H&E was no longer limited to the base of the oxyntic 
glands, but instead extended to the neck region (Fig. 2A). Cysts and vacuolization of 
gastric mucosa cells were also observed. 
The mislocalized cells in the KI/KI stomachs were further analyzed by 
immunohistochemistry (IHC). The hybridization signal with anti-Ki67 (a proliferation 
marker) in the gastric corpus of KI/KI mice was not only observed in the isthmus region 
(the normal proliferative zone in WT mice) but also extended along the whole neck and 
base of the oxyntic glands (Fig. 2B). ECL-cells (chromogranin A positive staining, 
Table S1) were localized at the base of the gastric oxyntic glands in WT stomachs (Fig. 
2C). However, in KI/KI mice, the staining pattern was no longer limited to the base, but 
was also extended through the neck region of the mucosa. Moreover, there was an 
increased number of chromogranin A-positive cells suggesting that ECL-cell number 
contributes towards the total mucosa hyperplasia observed in KI/KI mice. 
In humans who are homozygous for the mutation, the gastric somatostatin 
receptor (SSTR2) was found to be overexpressed in gastric ECL cells (Calvete et al., 
2015). In contrast, in KI/KI mice, no SSTR2 overexpression was observed by IHC 
(data not shown). The SSTR2 signal was also evaluated by PET-CT imaging. A SST 
analogue labeled with Gallium-68 (SST-68Ga) was used to detect differences in the 
expression of this receptor in KI/KI mice. No differences in the amount of SST-
68Ga/gram of stomach were observed between WT (Movie S1) and KI/KI animals 
(Movie S2). However, the SST-68Ga signal in the stomach was increased in KI/KI mice 
when normalized for the total amount of SST-68Ga absorbed by the animal (Table 1). 
This observation, together with the increased number of chromogranin A-positive cells, 
suggests that there is an increase in the number of cells expressing this receptor 
rather than an increased number of receptors per cell as observed in humans. 
The gastric mucosa was also evaluated with Alcian blue/PAS-staining. Blue 
staining, which localized to the base of the gastric mucosa in WT stomachs, was not 
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observed in KI/KI stomachs, which showed more irregular structure of the glands (Fig. 
2D). Moreover, mucous metaplasia was found in KI/KI mice. 
In summary, we observed loss of architectural integrity of the oxyntic glands in 
KI/KI stomachs which showed several similarities to the histopathological changes 
previously reported in the non-neuroendocrine tumor-affected areas of the gastric 
mucosa in patients harbouring the same mutation (Calvete et al., 2015). 
 
Gastric acid, serum gastrin concentration and anemia 
The patients described in Calvete et al. (2015) showed gastric achlorhydria and 
developed iron-deficiency anemia and hypergastrinemia. We therefore, proceed to 
study these parameters in mutant mice.  
Gastric pH was directly measured from the stomach content of mice at 
necropsy. No differences in pH were observed related to the age at the time of 
euthanasia and/or to the gender of the animals for any of the genotypes. However, 
highly increased gastric pH was observed in all KI/+ (pH 4) and KI/KI (pH 7) animals 
compared to WT mice (pH 1.5-2.5) (Fig. 3A). 
Anemia in the mice was evaluated by measuring ferritin concentration (ng/ml) in 
plasma. This parameter was observed to be different between genders (as expected) 
and was, therefore, analyzed separately in male and female mice. Significant 
differences in plasma ferritin concentration were found between sex-matched KI/KI 
animals compared to WT. This difference was more pronounced in females (p<0.01 for 
all measurements) than in males (p=0.013 at 300 days) (Fig. 3B) (Table 1). 
No difference in serum gastrin concentration was observed among the different 
genotypes at birth; however, marked hypergastrinemia (4-fold increase in mean serum 
gastrin concentration) was observed in KI/KI animals, relative to KI/+ and WT mice, at 
all the other time points analyzed (Fig. 3C) (Table 1). IHC of the antrum region of the 
stomach, where the G-cells are located, using both anti-gastrin and anti-Ki67 
antibodies (Table S1), showed no overexpression of gastrin or increased proliferation 
of G-cells in KI/KI compared to WT mice (Fig. 3D and 3E, respectively).  
WT animals showed the normal variation in serum gastrin concentration that is 
associated with feeding, with reduced concentrations being observed during the non-
feeding period (daytime). However, high serum gastrin concentrations persisted in 
KI/KI animals throughout the day and were not affected, to such an extent, by feeding. 
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(Fig. 3F). This suggests that there is an increased secretion of gastrin throughout the 
day, secondary to hypochlorydria and not just in response to feeding. 
In summary, KI/KI mice mimic all biochemical features of human patients who 
were homozygous for the ATP4a gene mutation (achlorhydria, hypergastrinemia and 
iron-deficiency anemia). This strongly suggests that the tested mutation in the ATP4a 
gene is primarily responsible for the development of these alterations. 
 
Prevention of the phenotypic changes in KI/KI mice 
 
In order to analyze the impact of low stomach pH on the development of the 
observed phenotypes in these mice, HCl-acidified drinking water (pH: 2.6-2.8) was 
initially given to the animals from birth. The gastric pH of all mice treated with acidified 
water was 2.5 and 4 for KI/+ and KI/KI animals, respectively. The treatment with 
acidified water did not cause macroscopic lesions in the stomach (see treated WT 
stomach in Fig. 4A) or esophagus (Fig. S2). 
Gastric hyperplasia was markedly reduced in acidified water-treated KI/KI mice 
compared to untreated KI/KI mice. Ultrasound echography also confirmed that gastric 
corpus thickness was reduced in treated compared to untreated KI/KI mice. The mass 
index was also partially restored (Table 1). H&E stained stomachs of these treated 
mice were also subject of histological examination. A slight gastric hyperplasia and 
some cells with dilated cytoplasms were still observed. However, no inflammation, loss 
of cellular polarity or any kind of metaplasia were found in the stomachs of treated 
KI/KI mice. Moreover, the normal oxyntic gland architecture was restored (Fig. 4B). 
Likewise, treatment of KI/KI mice with acidified water also led to normalization 
of the biochemical parameters. The extent of hypergastrinemia was reduced in 
acidified water-treated KI/KI mice (Fig. 4C) (Table 1). Gastrin concentration was only 
2-fold higher in treated KI/KI mice than in WT, instead of the 4-fold difference observed 
for non-treated mice. (Fig. 3C). No significant differences were found in ferritin 
concentrations between KI/KI and WT mice, of either gender, following acidified water 
treatment (Fig. 4D). Thus, administration of acidified water was sufficient for the 
restoration of iron absorption and prevented the onset of iron-deficiency anemia in 
KI/KI mice. 
The mislocalized hybridization signals observed in untreated KI/KI mice 
(described above) were also partially normalized following treatment with acidified 
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water. Anti-Ki67 and anti-chromogranin A immunostaining was mainly observed at the 
isthmus and the base of the gastric mucosa, respectively, in treated KI/KI mice (Fig. 
4E), as it was observed in WT mice. The gastric mucous metaplasia that was 
observed by Alcian blue/PAS-staining in KI/KI mice was no longer observed either in 
acidified water treated mice (Fig. 4F). 
Finally, the ratio SST-68Ga in the stomach per total SST-68Ga absorbed was 
reduced in treated KI/+ and KI/KI mice compared to non-treated mice (Table 1) again 
suggesting that the prevention of the histological alterations and normalization of the 
cell population was achieved in mutant mice by stomach pH acidification.  
 
Reversion of phenotypic changes in KI/KI mice 
 
In order to explore the potential of the stomach acidification treatment as a 
therapeutic approach, we next wanted to evaluate whether treatment with acidified 
water could, not only prevent, but also revert the development of the malignant 
phenotype of homozygous mutant mice. For this purpose, treatment with acidified 
drinking water (pH: 2.6-2.8) was started when mice were 150 or 250 days old and the 
effects were evaluated after 80 and 150 days of treatment in both cases. Gastric pH 
was partially restored in all treated mice: pH values of 2.5 and 4 were obtained for all 
KI/+ and KI/KI treated animals, respectively. After 150 days of treatment, starting both 
at 150 and 250 days of life, abnormal gastric morphology of the stomach was still 
found, however, the extent of gastric hyperplasia was reduced in treated versus non-
treated KI/KI mice (Fig. 5A). Larger responses were observed in the mice that started 
treatment at 150 days of age compared to those that started at 250 days of age. As in 
the prevention studies, gastric thickness and mass index were also partially restored 
compared to non-treated KI/KI mice (Table 1). 
Recovery of gastric histopathological changes was also observed in KI/KI mice 
after 150 days of treatment, although a certain degree of gastric disorganization and 
vacuolization still remained (Fig. 5B). Gastrin and ferritin concentrations were also 
partially restored in treated versus non-treated KI/KI mice (Fig. 5C and D) (Table 1). 
Serum gastrin concentrations decreased to a lesser extent in mice that started 
treatment at 250 days of age compared to those that started treatment at 150 days. 
However, in both scenarios, reduced serum gastrin concentrations were observed 
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after 150 days of treatment (Fig. 5C) similar to the levels observed in the prevention 
study. 
Immunohistochemistry using the anti-chromogranin A antibody also showed a 
partially normalized appearance in treated KI/KI mice (Fig. 5E). Most of the staining 
was observed at the base of the oxyntic glands as seen in WT mice. However, a 
certain degree of mislocalization through the gastric neck region still remained. 
Metaplasia was no longer observed, by Alcian blue/PAS staining, in the gastric 
mucosa of treated KI/KI mice (Fig. 5F). All these data indicate that the phenotype of 
KI/KI mice can also be reverted, at least to some extent, by normalization of the gastric 
pH and thus suggest gastric acidification as a potential alternative for therapeutic 
treatment of patients carrying this mutation.  
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DISCUSSION 
A knockin mouse line carrying the p.R702C mutation in the Atp4a gene in 
homozygosis, although normal at birth, developed most of the clinical features and the 
premalignant condition previously described in patients who are homozygous for the 
same mutation (Calvete et al., 2015). These include achlorhydria, hypergastrinemia, 
iron-deficiency anemia and gastric histopathological lesions. The stomachs of adult 
KI/KI mice exhibited severe hyperplasia, metaplasia and oxyntic glandular structural 
disorganization with dysplastic gastric glands. After one year, the mice did not develop 
gastric NETs, however, premalignant pathology and cellular dysplasia, similar to those 
observed in the non-tumor affected areas of the stomachs of human patients, were 
found. This is not an unusual finding since genetic mouse models often recapitulate, 
only partially, the pathologies associated to the human disease, even when the same 
genetic mutations are reproduced in their genome by gene targeting (Cheon and 
Orsulic, 2011). Intrinsic physiological differences between the two species may 
account for the limitations in reproducing human phenotypes in mice. Nevertheless, 
the early symptoms and the premalignant condition of the human disease are fully 
reproduced in our model facilitating the design and evaluation of therapeutic strategies 
for its prevention. 
Our model resembles other mouse models where hypoacidity and 
hypergastrinemic conditions have been shown to result in hyperplasia and often 
dysplasia of the gastric corpus, without the development of neoplasms in this region of 
the stomach (Fossmark et al., 2008). Previously described KO mouse models have 
suggested that gastrin, and not achlorhydria, is responsible for these phenotypes 
(Franic et al., 2001; Judd et al., 2005; Zavros et al., 2005). However, in our model, lack 
of acid production rather than gastrin deregulation, is more likely to be the major cause 
of the observed alterations in the stomach. Our KI/KI mice develop hypergastrinemia 
secondary to reduced acid secretion (Fig. 3F). Moreover, serum gastrin concentration 
in the evening was still higher in KI/KI mice than the one observed in wild type mice in 
the morning (after overnight feeding). This suggests that there is loss of the normal 
feeding-related physiological gastrin response in KI/KI mice.  
Acidification of the stomach by treatment with HCl water, not only prevented the 
development of the phenotype but, also, partially reverted it when administered to 
adult animals. This occurred despite a 2-fold persistent hypergastrinemia in treated 
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KI/KI mice compared WT mice, suggesting that low stomach pH is the primary cause 
of the phenotype observed.  
Therefore, our model supports the notion that the relationship between 
achlorhydria and hypergastrinemia and how they affect stomach hyperplasia and 
tumor development is still not fully understood. 
 
Comparison of human and mouse phenotypes 
KI/KI mice developed most of the analytical, clinical and premalignant 
characteristics that were previously observed in humans who harboured this mutation 
(ATP4a R703C) (described in Calvete et al., 2015). In humans with classic sporadic 
type I gastric NETs, the hypergastrinemia results in the development of multifocal 
malignancies and progressive PC destruction. As a consequence, patients develop 
megaloblastic anemia, due to vitamin B12-deficiency caused by the lack of IF 
production by PC cells. In contrast, IF was produced both in our patients, who had 
atypical familial gastric NETs (Calvete et al., 2015), and in our mouse model. 
Moreover, iron-deficiency anemia instead of megaloblastic anemia was observed in 
both mice and humans, due to the poor iron absorption at lower stomach pH. 
Although the mice did not develop gNETs, our result provides functional 
evidence that this mutation is the responsible of the observed phenotype in both, 
human and mouse by developing a gNET and the pre-neoplasic stage, respectively. 
We do not know if other modifier factors are required, in addition to the ATP4a 
mutation, to induce the development of NETs in the KI/KI mice. However, Helicobacter 
pylori infection or gastric inflammation as non-genetic factors were ruled out in humans, 
and other genetic factors such as mutations in REG1α, MEN1 or SMAD4 that are 
genes involved in other gastric or NE cancers were not mutated in human patients. So, 
other studies are necessary in order to decipher this issue. 
In addition, we think that the differences between human and mouse in 
response to hypergastrinemia could be an important factor for the development of 
gNETs because an overexpression of SSTR2 signal was observed in human tumors 
(Calvete et al. 2015) while in the mouse model, SSTR2 was not observed to be 
overexpressed in individual ECL-cells. Instead, the increased ratio SST-68Ga absorbed 
in the stomach/total SST-68Ga absorbed suggests that there is an overall increase in 
the number of ECL cells in the mutant mice in response to achlorhydria and 
hypergastrinemia, rather than an increase in the number of SSTR2 receptors per cell. 
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This is consistent with the gastric mucosa hyperplasia (higher total cell number) 
observed in KI/KI mice. However, these differences must be deeply explored. 
 
Gland architecture 
No hyperplasia or increased expression of gastrin or Ki67 were observed in the 
gastric antrum of KI/KI mice, although gastrin concentration was not observed to 
decrease during the non-feeding period in KI/KI mice (Fig. 3F), therefore suggesting 
that hypergastrinemia results from a more persistent and less feeding-dependent 
gastrin production by G-cells than from an increase in the G-cell population in this 
model. 
In the gastric corpus of KI/KI mice, PC viability and number were not 
compromised in contrast to what has been previously described in Atp4a KO mice 
(Spicer et al., 2000) and in the hypochlorhydric and gastrin-deficient mice described by 
Zavros et al. (Zavros et al., 2005). Differences observed between the Atp4a KO mouse 
and our KI model might be related to the absence or non-functionality of the ATP4a 
protein, respectively. In the KO mice, the protein is not produced and this might affect 
PC viability in a different way as the point mutation here described. 
PCs have been described to regulate the biology of the niche for cells of the 
gastric oxyntic glands and the maturation and differentiation of epithelial neck 
(isthmus) cells to chief cells (base of mucosa)(Bredemeyer et al., 2009). Disruption of 
this lineage patterning has been correlated with the development of stomach cancer. 
Achlorhydria in KI/KI mice altered the architecture of the oxyntic glands. Moreover, cell 
proliferation patterns and cell localization were also altered in KI/KI mice. A delocalized 
IHC signal of Ki67 has also been described in somatostatin-deficient mouse models 
(Zavros et al., 2005). This delocalization suggests that progenitor cells (neck mucosa 
cells) do not differentiate adequately throughout the gland. Therefore, achlorhydria 
appears to induce cell delocalization along the oxyntic gland and glandular metaplasia. 
 
Treatment and preclinical applications 
In KI/KI mice, the achlorhydria that resulted from the missense mutation in the 
proton pump was partially corrected by administering acidified water in both prevention 
and reversion scenarios. The dysplasia, cellular delocalization and glandular 
metaplasia observed in the stomachs of untreated KI/KI mice disappeared after 
treatment with acidified water (Figs. 4B, E and F and 5B, E and F). Hypergastrinemia 
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and iron-deficiency anemia, that result from gastric achlorhydria, were also not as 
pronounced in treated compared to non-treated KI/KI mice. Therefore, achlorhydria 
appears to cause the observed phenotype. We also partially restored the iron-
deficiency anemia in treated KI/KI mice. 
Treatment for gastric NETs can be expensive and the aggressive forms require 
major surgery that diminishes life quality. Our results indicate that the phenotype of 
KI/KI mice can be reverted, at least to some extent, by normalization of the gastric pH. 
We speculate that by administering a treatment that induces a more acidic gastric pH 
without damaging other tissues, the development of gastric pathology in humans might 
be prevented or reverted effectively and at low cost. Our findings may also open a new 
window for a cheap and non-aggressive alternative to reduce the impact of gastric 
pathologies and other pathologies that arise from achlorhydria or hypergastrinemia. 
Clinical application of this finding for treatment of gastric pathologies is therefore 
immediately inferred, but further studies are required for establishing the best 
treatment for NET patients. 
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MATERIALS AND METHODS 
 
Study approval 
All animal procedures were previously approved by CNIO (Register number: 
IACUC.043-2014) and the Institutional Animal Ethics Committee (Register number: 
PROEX292/14). 
 
Knockin mice Construction 
 
Mice were housed in a specific pathogen free (SPF) barrier facility. 
C57Bl/6JOlaHsd mice were obtained from the in-house colony. The p.R702C 
mutation in the Atp4a gene was introduced into the mouse germ line by gene 
targeting in the G4 embryonic stem (ES) cell line (George et al., 2007) following 
protocols previously described. The targeting vector was designed to target exon 14 
of the Atp4a gene, introducing the mutation (CGA (R) to TGC (C)) at position 702 and 
a silent mutation in codon 709 (CTG (L) to CTT (L) to create a HindIII restriction site 
(AAGCTT) for easy genotyping. For clone selection, a Frt-flanked PGK/bg2-neoR 
cassette was introduced into the intron preceding 5´ to exon 13, with a transcriptional 
orientation opposite to that of the Atp4a gene. Homology arms were obtained from 
BAC RP23-72M20 and the lengths were 4.8 Kb and 6.0 Kb for the 5’ and 3´arms, 
respectively (Fig. S1). Clones selected in G418 (200 g/ml) for one week were 
screened by Southern blot using external probes amplified from the BAC DNA 
following the strategy described in Fig. S1. The 5´ external probe (289 bp) was 
amplified using primers forward 5´-CCCTGTCTCCAAAAACCAAA-3´ and reverse 5´-
CGGCTTTGTGCATAGGAGTT-3´. The 3´ external probe (366 bp) was amplified 
using primers forward 5´-AAAACACACCCCCATTTGAA-3´ and reverse 5´-
CTTTTGCCTTCCTCAGATGC-3´. Of 147 clones screened, 4 were positive for 
recombination in both arms and three of these were positive for both mutations in 
exon 14. Germ line transmitting chimeras were generated from 2 of the mutant 
clones that contained the p.R702C mutation by morula aggregation. The knockin line 
was established from chimeras derived from one of these clones. To delete the 
PGK/bg2-neoR cassette, heterozygous mice (+/KI) were crossed with Tg.CAG-Flp 
females (Nagy et al., 2003) and the Flp-mediated excision of the PGK/bg2 neo 
cassette was verified by Southern blot (Rodríguez et al., 2000). After cassette 
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excision, the line was maintained by crossing heterozygous (+/KI) mice. Littermates 
of the three genotypes, WT, KI/+ and KI/KI, were used in the experiments. The line 
was maintained in a 129S6/SvEv, C57BL/6J mixed background. 
Mouse genotyping was performed by PCR. Primers were designed to amplify 
sequences flanking the Frt site left in intron 12 after Flp-mediated recombination. 
Forward (5’-CCCTCCCTCAGCTTATTTCC-3’) and reverse (5’-
GTCTCACCAGTCGCTGACAA-3’) primers amplified 166 bp and 233 bp fragments 
from WT and KI alleles, respectively (Fig. 1F). Genotyping was performed from DNA 
extracted from tail tissue (DNAeasy® Blood & Tissue Kit. Cat. No. 69504) at weaning. 
 
Blood samples 
Blood was collected from mice by retro-orbital bleeding between 9 and 10 AM 
to reduce feeding-related differences. Plasma and serum were obtained from blood 
after 10 minutes of centrifugation at 3000 rpm in an Eppendorf centrifuge at room 
temperature and were collected in 2 mL Heparin-tubes (REF 368494 from BD 
Vacutained®) and Eppendorf tubes, respectively.  
 
Macroscopic analysis  
At necropsy, stomachs were carefully dissected, measured and weighed after 
elimination of food contents. Stomach pH was measured using a colorimetric pH 
indicator (0-14) strip. After dissection, a pH strip was introduced into the stomach 
before rinsing the tissue. 
 
Echography 
Four different regions were assessed: corpus, antrum, pylorus and duodenum 
junctions. During the ultrasound study, mice received general anesthesia (isoflurane 
2-3%). A Vevo 770 ultrasound imaging platform (Visualsonics) and a RMV 703 
transducer were used. 
 
Gastrin Measurement  
Serum samples were assayed for total amidated gastrin concentrations by 
radioimmunoassay using antibody L2 (which reacts with G-17 and G-34 but not with 
progastrin or Gly-gastrins) and I-G-17 as previously described (Dockray et al., 1991). 
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The upper limit of the reference range for serum gastrin in normal mice is 150 pM in 
this assay. 
 
Ferritin Measurement 
Ferritin was measured in plasma by using a hematology analyzer (ABX Pentra 
400 from Horiba Medicals). For ferritin measurement, we used ABX Pentra Ferritin 2 
CP (Ref. A11A01900), which uses ABX Pentra Immuno II Control L/H as control (Ref. 
A11A01622) and is calibrated with ABX Pentra Ferritin Calibrator (Ref. A11A01619). 
 
PET/CT imaging and biodistribution 
The peptide DOTA-D-Phe1,Tyr3-octreotate (DOTA-TATE), a somatostatin 
analog, which has a high affinity for the SSTR2 subtype somatostatin receptor, was 
labeled with 68Ga obtained from a 68Ge/68Ga radionuclide generator. 
PET studies were performed in an Argus PET/CT (SEDECAL). Images were 
acquired for 30 min under anesthesia (2-2.5% isoflurane in 100% O2 at a flow rate of 
5% using a Fluovac device) 60 minutes after i.v. injection of 68Ga-DOTA-TATE (0.2-2 
MBq). PET images were corrected for random events and scatter without attenuation 
correction, reconstructed using the 2D-OSEM algorithm and fused with the 
corresponding CT images. 
For biodistribution studies, organs were excised, wet-weighed and counted for 
radioactivity with a gamma-counter (2470 Wizard2, PerkinElmer), along with a 
standard sample of the injected dose. Tissue activity was expressed as percentage 
of the injected dose per gram of tissue (%ID/g).  
 
Histology and immunohistochemistry 
Stomachs and esophagi were collected, fixed in 10% formalin and embedded 
in paraffin. Blocks were cut into 5 μm-thick sections. Details of the antibodies, 
incubation conditions and antigen retrieval methods are given in Table S1. 
 
Treatment with acidified water 
Artificial acidification of the gastric juice was achieved by providing acidified 
water (pH: 2.6-2.8) to the mice as drinking water for the times established. Water was 
acidified by adding 0.215 mL of pure HCl (12N) per liter of water (pH: 7) after 
autoclaving. 
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Statistical analysis 
Significance of differences among individuals grouped according to genotype 
(WT vs. KI/KI) was evaluated with the non-parametric Kolmogorov-Smirnov test to 
determine normal distribution of values within the groups. Student’s t-test was used 
for comparison of normally distributed values among genotypes. Differences were 
considered to be significant when the exact p value was <0.05. 
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FIGURE LEGENDS:  
 
Fig. 1. Stomach hyperplasia in mutant mice. (A) Macroscopic images of WT, KI/+ and 
KI/KI stomachs: external (left images) and internal (right images). Images are 
representative examples of stomachs from mice at birth and more than 1 year old, 
respectively. Scale bar: 1 cm. (B) Gastric antrum thickness (μm) over time. (C) Gastric 
corpus thickness (μm) over time. (D) Stomach Mass index (weight of the stomach 
normalized by the total weight of the animal) over time. (E) Size index (size of the 
stomach normalized by the total weight of the animal) over time. n=6 per genotype. ns: 
not significant. 
 
Fig. 2. Histological alterations in the corpus region of the stomach. (A) 
Representative H&E staining of a transverse section of stomach from mice at one year of 
age. In WT mice, progenitor cells are located in the isthmus (asterisk), PCs (basic 
staining) stain magenta with H&E and are located in the neck (black arrow). ECL-cells 
and zymogenic cells (acid staining) stain dark purple with H&E and are located at the 
base of oxyntic glands (grey arrow). In KI/KI mice, cellular disorganization and increased 
thickness of the stomach wall were observed; characterized by the presence of 
proliferating cells (at isthmus in WT mice) and ECL-cells (at base in WT mice) within the 
neck region of gastric corpus glands (asterisk). In addition, high numbers of epidermoid 
cysts surrounded by a single layer of cuboidal epithelium (grey arrowhead), vacuolization 
of gastric mucosal cells (white arrow) and widely opened lumen of the oxyntic glands 
(white arrowhead) were seen in KI/KI mice. In the enlarged image at the far right, 
increased number of grouped cells from the isthmus region (black arrowhead), dysplastic 
cytoplasms of PCs (black arrow) and hyalinosis (light grey arrow), indicating a 
premalignant condition, are shown. (B) IHC of gastric corpus stained with anti-Ki67 
antibody. In WT mice, the staining is limited to the isthmus region, which is the 
proliferative zone. Increased Ki67 staining is observed in the KI/KI stomach isthmus, but 
is also seen in the neck region (black arrow). (C) IHC of gastric corpus stained with anti-
chromogranin A antibody. In WT mice, the staining is limited to the base of the oxyntic 
glands while in KI/KI stomachs it is also seen in the entire neck region (black arrows). (D) 
Alcian Blue/PAS staining of the corpus region of the stomach of WT (left image) and 
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KI/KI (right image) mice. White arrows show areas of glandular metaplasia in the KI/KI 
stomach. 
 
Fig. 3. Hypoacidity, anemia and hypergastrinemia in KI/KI mice. (A) Gastric pH 
values determined by direct measurement with colorimetric paper at necropsy. 
Measurements of two different animals are shown for each genotype; gastric pH values 
were approximately, 1, 4 and 7 for WT, KI/+ and KI/KI mice, respectively. (B) Ferritin 
concentrations in plasma (mM) of WT, KI/+ and KI/KI male (left panel) and female mice 
(right panel). (C) Gastrin measurements: Gastrin concentrations in serum (pM) of WT, 
KI/+ and KI/KI mice. (D) Representative IHC images of the antrum region of the stomach 
stained with anti-gastrin antibody in WT and KI/KI mice at 350 days of age. In both 
genotypes, the anti-gastrin antibody labels G-cells at the base of pyloric glands (black 
arrows). (E) IHC with anti-Ki67 antibody of the gastric antrum from representative WT 
and KI/KI mice. In both genotypes, progenitor cells are located at the base of pyloric 
glands (asterisks). (F) Gastrin concentrations in serum (pM) of WT, KI/+ and KI/KI mice. 
n=6 per genotype. ns: not significant. 
 
Fig. 4. Phenotype prevention by treatment with HCl water. (A) Macroscopic images of 
stomachs. Representative external (left images) and internal (right images) images of 
stomachs are shown for HCl-water treated and untreated WT and KI/KI mice at >350 
days of age. No lesions or injuries were observed in WT mice following this treatment. 
Gastric hyperplasia in treated KI/KI mice (pH=4) is drastically reduced compared to KI/KI 
mice without treatment (pH=7). Scale bar: 1 cm. (B) Representative H&E staining images 
of KI/KI stomachs from treated mice compared to WT and non-treated KI/KI mice at 350 
days of age. Similar architecture consisting of progenitor neck mucosa cells located in 
the isthmus (asterisks), PCs in the neck (black arrows), and ECL and zymogenic cells in 
the base of oxyntic glands (dark grey arrows) were observed in WT and treated KI/KI 
stomachs. Widely opened oxyntic glands (white arrowhead), grouped nuclei from the 
isthmus region (black arrowhead) and hyalinosis (light grey arrow), observed in untreated 
KI/KI stomachs, were not detected in treated mice. (C) Serum gastrin concentrations 
(pM) in WT, KI/+ and KI/KI mice treated for the times indicated. (D) Ferritin 
M) of treated WT, KI/+ and KI/KI males (upper panel) and 
females (lower panel). (E) IHC of corpus region of a representative treated KI/KI stomach 
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with anti-Ki67 (left panel) and anti-chromogranin A (right panel) antibodies. Staining is 
limited to the isthmus and the base of the oxyntic glands, respectively, as observed in 
WT mice (Fig. 2B). (F) Alcian Blue/PAS staining of the corpus region of a representative 
KI/KI stomach from a 350 day old mouse. n=6 per genotype. ns: not significant. 
 
Fig. 5. Phenotype reversion by treatment with HCl water. (A) Macroscopic images of 
stomachs. Representative external (left images) and internal (right images) images of 
stomachs are shown for KI/KI mice after 150 days of treatment starting at 150 or 250 
days of age. Gastric hyperplasia in KI/KI mice treated (pH=4) from day 150 was 
drastically reduced compared to untreated KI/KI mice (pH=7). The extent of gastric 
hyperplasia reduction was less evident in mice that started treatment at 250 days of age. 
See Table 1 for gastric thickness data. Scale bar: 1 cm. (B) Corpus region of a stomach 
from a KI/KI mouse treated for 150 days starting at 150 days of age stained with H&E. 
Cellular organization was partially restored in treated mice. Major lesions also 
disappeared in these mice compared to KI/KI mice without treatment. In treated KI/KI 
stomachs, progenitor neck mucosa cells were located in the isthmus (black asterisk), 
PCs in the neck (black arrow), and ECL and zymogenic cells at the base of oxyntic 
glands (dark grey arrow). Widely opened oxyntic glands (white arrowhead), grouped 
nuclei from the isthmus region (black arrowhead) and hyalinosis (light grey arrow), 
observed in KI/KI stomachs, were not observed in treated KI/KI stomachs. (C) Serum 
gastrin concentrations (pM) in WT and KI/KI mice treated for 80 and 150 days of 
M) for male and female mice after 150 
days of treatment. (E) IHC staining with anti-chromogranin A antibody of the corpus 
region of a representative KI/KI stomach after 150 days of treatment. (F) Alcian Blue/PAS 
staining of the corpus region of a representative KI/KI stomach after 150 days of 
treatment. n=6 per genotype. ns: not significant. 
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Table 1. Summary of the representative phenotypic data from 350-400 day old mice, including prevention and reversion studies. 
 
  Genotype 
Thickness (μm) Mass 
Index  
Size 
Index  
Ferritin (ng/ml) 
Gastrin (pM) SST-68Gaa  
Corpus Antrum Male Female 
Mouse model WT 306.92 205.16 0.60 6.45 50.95 59.05 118.8 1.57 
 
KI/+ 709.39 150.79 0.87 5.46 29.60 44.80 97.75 2.29 
 
KI/KI 1398.70+ 255.81 2.61+ 6.23 36.15+ 29.53+ 368.67+ 5.54+ 
Prevention* WT 224.89 207.35 0.66 4.61 44.55 41.00 20.55 1.81 
  KI/KI 598.15 245.89 1.20 6.03 40.05 37.35 199.3+ 4.23 
Reversion** WT 206.45 177.04 NT NT NT NT 67.5 NT 
 
KI/KI 943.65 143.89 NT NT NT NT 199.5+ NT 
Reversion*** WT 343.32 144.43 0.61 4.10 45.90 59.1 28.65 NT 
  KI/KI 1018.5 227.67 2.17 5.13 55.07 57.2 197.89+ NT 
 
NT: Not tested; *: Mice treated with HCl water from birth; **: Mice starting treatment at 150 days of age; ***: Mice starting 
treatment at 250 days of age. +: Significantly different in KI/KI compared to WT (p<0.001). a: % SST-68Ga quantified in the 
stomach / % total amount of SST-68Ga absorbed by the animal. 
Standard deviations are not shown in the Table (see Figures for details). 
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